2018 AANS Annual Scientific Meeting-584. The rise of the Acinetobacter baumannii: A meta-analysis on role of intra-thecal anti-microbial therapy in reduction of mortality

584. The rise of the Acinetobacter baumannii: A meta-analysis on role of intra-thecal anti-microbial therapy in reduction of mortality

Back to course

Video Transcription

Video Summary

In this video, Nasser Mohamed, a postdoctoral fellow in the Department of Neurosurgery at Louisiana State University, discusses the rise of infections caused by Acinetobacter gumani in post-neurosurgical patients. He explains that multidrug-resistant organisms have become a significant concern in critical care management, and Acinetobacter gumani has emerged as a leading cause of mortality in these infections. Mohamed presents a meta-analysis study on the role of intrathecal antimicrobial therapy in reducing mortality rates. The study shows that combining intravenous and intrathecal therapy significantly reduces the odds of dying from Acinetobacter gumani infections in post-neurosurgical patients. However, there is still a need for further research and consideration of optimal dosages and timings for intrathecal therapy.

Asset Caption

Nasser Mohammed

Keywords

Nasser Mohamed

Acinetobacter gumani

post-neurosurgical patients

multidrug-resistant organisms

intrathecal antimicrobial therapy